Advertisement
Advertisement
VCRE
Vicore Pharma Holding AB - ADR
11.35
USDSponsored
+0.08
+0.71%
Nov 10, 15:59 UTC -5
Closed
After-Market
11.30
-0.05
-0.44%
Vicore Pharma Holding AB - ADR (VCRE) Earnings
VCRE Earnings Reports
Positive Surprise Ratio
VCRE beat 2 of 3 last estimates.
67%
Next Report
Date of Next Report
Feb 27, 2027
Estimate for Q4 26 (Revenue/ EPS)
$382.84K
/-$0.53
Implied change from Q3 26 (Revenue/ EPS)
-35.55%
/+20.45%
Implied change from Q4 25 (Revenue/ EPS)
--
/-1.85%
Vicore Pharma Holding AB - ADR earnings per share and revenue
On Nov 05, 2026, VCRE reported earnings of -0.44 USD per share (EPS) for Q3 26, beating the estimate of -0.52 USD, resulting in a 15.42% surprise. Revenue reached 594.00 thousand, compared to an expected 382.84 thousand, with a 55.16% difference. The market reacted with a +6.04% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.53 USD, with revenue projected to reach 382.84 thousand USD, implying an increase of 20.45% EPS, and decrease of -35.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Novanta Inc. Tangible Equity Units
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.98
Actual
$1.05
Surprise
+6.49%
Horizon Quantum Holdings Ltd. Class A Ordinary Shares
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.70
Surprise
+720.53%
BTC Development Corp. Unit
Report Date
Nov 10, 2026 For Q3 26
Estimate
-Actual
$0.06
Surprise
-
Atlanticus Holdings Corporation 9.25% Senior Notes due 2029
Report Date
Nov 05, 2026 For Q3 26
Estimate
$3.04
Actual
$4.87
Surprise
+59.78%
Atlanticus Holdings Corporation 6.125% Senior Notes due 2026
Report Date
Nov 05, 2026 For Q3 26
Estimate
$3.04
Actual
$4.87
Surprise
+59.78%
Gladstone Investment Corporation 4.875% Notes due 2028
Report Date
Nov 09, 2026 For Q2 27
Estimate
$0.28
Actual
$0.18
Surprise
-37.52%
Gladstone Investment Corporation 7.875% Notes due 2030
Report Date
Nov 09, 2026 For Q2 27
Estimate
$0.28
Actual
$0.18
Surprise
-37.52%
Emera Incorporated
Report Date
Nov 06, 2026 For Q3 26
Estimate
$0.92
Actual
$0.85
Surprise
-7.81%
Brookfield Infrastructure Corporation Class A Exchangeable Subordinate Voting Shares
Report Date
Nov 06, 2026 For Q3 26
Estimate
$0.43
Actual
-$0.04
Surprise
-109.12%
WhiteHorse Finance, Inc. 7.875% Notes due 2028
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.25
Actual
$0.22
Surprise
-13.15%
FAQ
What were Vicore Pharma Holding AB - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Vicore Pharma Holding AB - ADR reported EPS of -$0.44, beating estimates by 15.42%, and revenue of $594.00K, 55.16% above expectations.
How did the market react to Vicore Pharma Holding AB - ADR's Q3 2026 earnings?
The stock price moved up 6.04%, changed from $9.44 before the earnings release to $10.01 the day after.
When is Vicore Pharma Holding AB - ADR expected to report next?
The next earning report is scheduled for Feb 27, 2027.
What are the forecasts for Vicore Pharma Holding AB - ADR's next earnings report?
Based on --
analysts, Vicore Pharma Holding AB - ADR is expected to report EPS of -$0.53 and revenue of $382.84K for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.